WITHDRAWN: Neuropathic Cancer Pain in Patients Treated With an EGFR-Inhibitor

J Pain Symptom Manage. 2021 Jun 20:S0885-3924(21)00401-2. doi: 10.1016/j.jpainsymman.2021.06.018. Online ahead of print.

Authors

Marte Grønlie Cameron¹, Christian Kersten²

Affiliations

¹ Center for Cancer Treatment, Sørlandet Hospital Trust, Kristiansand, Norway. Electronic address: [email protected].
² Department of Research, Sørlandet Hospital Trust, Kristiansand, Norway.

PMID: 34161812
DOI: 10.1016/j.jpainsymman.2021.06.018

Abstract

This article has been withdrawn because of a publisher error. It should not have been posted.

Keywords: Cancer pain; EGFR-inhibitor; Neuropathic pain; Palliative outcomes; Panitumumab; Study design.

Copyright © 2021. Published by Elsevier Inc.